European Regulator Calls for Amgen’s Tavneos to Have Authorization Revoked
European regulators are recommending the revocation of marketing authorization for Amgen's autoimmune disease drug, Tavneos.
Evidence dossier
Intelligence passport
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
- Latest coverage observed Most recent article currently attached to this story cluster.
- Peak measured velocity The recorded velocity reached 6.
- Outcome review added Archynetys revisited the signal after coverage cooled.
Source diversity sample: FirstWord Pharma · Citeline News & Insights · Bloomberg · Medscape · Fierce Pharma · Endpoints News · Reuters · WSJ.
How this dossier is built: methodology · AI policy · corrections.
📍 Where it landed
European regulators and the CHMP recommended revoking the marketing authorization for Amgen's Tavneos after study data was found unreliable. Simultaneously, the FDA pursued efforts to pull the drug over alleged data manipulation.
Epilogue added 56d ago, after coverage quieted.
The reporting (8)
- Latest CHMP decisions led by recommendation to revoke approval of Tavneos FirstWord Pharma · 66d ago
- CSL Faces EU Withdrawal Of Tavneos After EMA Finds Study Data Unreliable Citeline News & Insights · 66d ago
- Inside FDA’s Effort to Pull an Amgen Drug Over Alleged Data Manipulation Bloomberg · 66d ago
- New Data Lead to Decision to Revoke Autoimmune Disease Drug Medscape · 66d ago
- Europe's CHMP reverses endorsement of Tavneos as Amgen FDA hearing looms Fierce Pharma · 66d ago
- EU regulators recommend revoking the marketing authorization for Amgen’s Tavneos Endpoints News · 66d ago
- EU regulator backs revoking Amgen's right to sell rare-disease drug Reuters · 66d ago
- European Regulator Calls for Amgen’s Tavneos to Have Authorization Revoked WSJ · 66d ago
What happened
The Committee for Medicinal Products for Human Use (CHMP) has reversed its endorsement of Tavneos. This recommendation would revoke Amgen's right to sell the rare-disease drug within the European market.
Coverage from Reuters, WSJ, Endpoints News, Fierce Pharma, and Medscape emphasizes that the decision follows the emergence of new data. The move comes as Amgen faces an upcoming hearing with the FDA.
Attention now turns to the outcome of the FDA hearing and the final implementation of the CHMP's recommendation regarding the drug's authorization.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 66d ago.
Questions people are asking
What drug is affected by the regulator's decision?
Tavneos, a drug developed by Amgen for autoimmune and rare diseases.
Why is the authorization being revoked?
According to Medscape, the decision was led by new data.
Which regulatory body issued the recommendation?
The CHMP (Committee for Medicinal Products for Human Use) in Europe.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
FDA Announces Tofu Recall: More Than 10,000 Cases May Be Contaminated With Ink
The FDA has announced a recall of over 10,000 cases of tofu, potentially contaminated with ink, affecting 29 states.
Pet food recalled over salmonella, listeria risks
A nationwide recall of nearly 2,000 pounds of raw pet food over salmonella and listeria risks has drawn attention across major news outlets.
Check your cabinets: White rice recalled in 13 states
The FDA has expanded a recall of white rice to 13 states, but the exact nature of the contamination is unclear.
Icelandic voters reject a proposal to restart negotiations to join the European Union
Icelandic voters have rejected a proposal to restart negotiations to join the European Union
Iceland rejects EU accession talks in referendum
Iceland's rejection of EU accession talks leaves the country's future in a state of uncertainty.
Close race as Iceland votes on whether to restart talks on joining EU
Icelanders vote on whether to restart talks on joining the EU, with the outcome too close to call
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.